1.
Aguilar C, Rodríguez-Delfín L. Effects of spironolactone administration on the podocytes loss and progression of experimental diabetic nephropathy. Rev Peru Med Exp Salud Publica [Internet]. 2014 Feb. 5 [cited 2024 Dec. 15];29(4). Available from: https://rpmesp.ins.gob.pe/index.php/rpmesp/article/view/393